Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients
Marie Diener-West
Annals of Surgery, 2001
View PDFchevron_right
Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study
Nikhil Khandelwal
Critical Care, 2014
View PDFchevron_right
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit
Michele Mussap
Journal of Antimicrobial Chemotherapy, 2009
View PDFchevron_right
A Prospective Observational Study of Risk Factors for Candida glabrata in an SICU: Role of Fluconazole
Chris Gentry
Hospital Pharmacy, 2007
View PDFchevron_right
Empirical treatment of candidemia in intensive care units: Fluconazole or broad-spectrum antifungal agents?
Teresa Peláez
Medical Mycology, 2009
View PDFchevron_right
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients
Susan McCormick Hadley
Annals of Internal Medicine, 2008
View PDFchevron_right
The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis
Geoffrey Dobb
Critical Care, 2005
View PDFchevron_right
Are prophylactic antifungals in highly colonized patients safe and effective?
Cristóbal León
Intensive Care Medicine, 2015
View PDFchevron_right
Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital
M Basso
Medical Mycology, 2008
View PDFchevron_right
Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis
Carlo Mengoli, M. Cruciani
View PDFchevron_right
Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials
Niki Paphitou
Medical Mycology, 2005
View PDFchevron_right
Fluconazole therapy for treatment of invasive candidiasis in Intensive Care patients. Is it still valid from a pharmacological point of view
Paolo Mura
2014
View PDFchevron_right
Incidence of candidemia before and after fluconazole prophylaxis implementation in a 14-bed general ICU
L. Kondili
Critical Care, 2008
View PDFchevron_right
Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study
Estefanía Gracia, Gerardo Aguilar
BMC Research Notes, 2015
View PDFchevron_right
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials
massimo attanasio
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Choice of initial antifungal therapy in critically Ill patients
sudha madhavan
International Journal of Health Sciences (IJHS), 2022
View PDFchevron_right
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study
Tobias Bingold
Infection and Drug Resistance, 2013
View PDFchevron_right
A bedside scoring system (???Candida score???) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization
Pedro Saavedra
Critical Care Medicine, 2006
View PDFchevron_right
Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit
S Faiz
European Journal of Clinical Microbiology & Infectious Diseases, 2008
View PDFchevron_right
Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study
Jesús Gomez
Critical care medicine, 2017
View PDFchevron_right
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care
Gabriele Sganga
Intensive Care Medicine, 1998
View PDFchevron_right
Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: What do the guidelines recommend?
M. Van Driel
International Journal of Infectious Diseases, 2019
View PDFchevron_right
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study
Katie Suda
Clinical Infectious Diseases, 2006
View PDFchevron_right
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
J. Kosterink
Antimicrobial Agents and Chemotherapy, 2021
View PDFchevron_right
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study
Thomas Bregenzer
The Journal of infection, 2018
View PDFchevron_right